Skip to main content
. 2016 Jul;99:147–154. doi: 10.1016/j.tube.2016.05.014

Table 4.

Comparing the proportion of drug resistant Ghana spoligotype of MTBSS to other prominent spoligotypes in the Ghana.

Resistance Cameroon (806) Ghana (195) OR 95% CI p-value
INH 54 (6.7%) 43 (22.1%) 0.25 0.16–0.40 0.0000
RIF 19 (2.4%) 12 (6.2%) 0.37 0.17–0.85 0.0103
MDR 13 (1.6%) 9 (4.6%) 0.34 0.13–0.91 0.0240
ANY 60 (7.4%) 46 (23.6%) 0.26 0.17–0.41 0.0000
MAF WA 1 (165) Ghana (195)
INH 25 (15.2%) 43 (22.1%) 0.63 0.35–1.12 0.1059
RIF 10 (6.1%) 12 (6.2%) 0.98 0.37–2.56 0.9998
MDR 10 (6.1%) 9 (4.6%) 1.33 0.47–3.81 0.6384
ANY 25 (15.2%) 46 (23.6%) 0.58 0.32–1.02 0.0472
MAF WA 2 (107) Ghana (195)
INH 6 (5.6%) 43 (22.1%) 0.21 0.07–0.52 0.0001
RIF 1 (0.9%) 12 (6.2%) 0.144 0.00–1.00 0.0372
MDR 1 (0.9%) 9 (4.6%) 0.19 0.00–1.45 0.1040
ANY 6 (5.6%) 46 (23.6%) 0.19 0.06–0.48 0.0000

MAF WA 1: M. africanum West Africa 1 (Lineage 5).

MAF WA 2: M. africanum West Africa 2 (Lineage 6).

Significantly higher.